ABSTRACT
INTRODUCTION
There are several research situations where gene dosage is important. Cell lines, derived from tumors may carry an altered gene dose of mutant genes. These cell lines may change this gene dose during passage in tissue culture. The copy number of transfected genes integrated into the genome may need to be determined. In the past, Southern analyses were used to quantify the ratio of mutant-to-wild-type c -Ha-ras alleles (16) . Quantifying Southern analyses, however, can be a problem due to transfer and hybridization differences of DNA fragments of various lengths, background in the lane, incomplete cutting of DNA and the uneven loading of lanes. Cytogenetics have been used as an addition to Southern analyses to determine the copy number (4) . An alternative method of determining gene dose, the probing of polymerase chain reaction (PCR)-amplified alleles with mutation-specific oligonucleotides (3), requires two hybridization steps and the adjustment of exposure times for probe-specific activity and hybridization efficiency.
The PCR method described here is time-efficient and accurate for establishing the copy number of mutant and wild-type alleles. Previously, singlestage PCR amplification of alleles combined with mutation-specific restriction fragment formation has been the basis for detection of rare mutations in a background of wild-type alleles (10) . Nested PCR, previously used to detect rare mutant alleles (12) or rare viral copies (18) , is used here to enrich the gene of interest in relationship to the genome in the first stage, allowing the second stage to be used for the incorporation of radioactive nucleotides. Optimization for Mg ++ ion, nucleotide levels or annealing temperature was not necessary for each new gene. Phosphor imaging techniques provide wide linear range with ease of quantitation and without use of X-ray film.
MATERIALS AND METHODS

DNA Sources
CD-1 strain mouse epidermal tissue (7) was the source of wild-type c -Haras alleles. PDV is a tumorigenic mouse keratinocyte cell line, shown by Southern analyses of Xba I digests to have a 2:1 ratio of wild-type c -Ha-ras alleles per mutant 61st codon allele, (CAA→CTA) (1) . A total of three cHa-ras gene copies was established by cytogenetics (4) . This cell line serves as a control in the validation of the assay for gene copies. CarB is a tumorigenic spindle cell carcinoma keratinocyte line, homozygous for the same c -Haras61st codon A→T mutation (3). DU145 is a human prostate cell line (15) , with no known mutations in the matrix metalloprotease matrilysin gene. MR-15 clone 24 is a DU145 line, transfected with a cDNA plasmid carrying a mutant 89th codon allele GTG→GGG in the second exon (13) . An additional Sau 96I restriction site is formed by this mutation. 
Sho r t Technical Repo r t s
DNA Preparation
DNA was purified by proteinase K, RNase and phenol/chloroform/isoamyl alcohol extractions (5). High-molecular-weight DNA was spooled out, quantitated by spectrophotometry and digested with 5 U/ µ g Pst I and 5 U/ µ g Hin dIII Table 1 lists the components of the first-stage PCR. A 50-µ L amplification reaction was started with the addition of UlT ma ™DNA Polymerase (PerkinElmer, Norwalk, CT, USA) in 10 µ L of 1 ×UlT ma Buffer into a DNA mixture preheated to 85°C on a Cetus ™DNA Thermal Cycler (Perkin-Elmer). After an initial denaturation for 2 min at 97°C, 20 cycles of PCR were carried out for 1 min at 97°C, 1 min at 60°C and 1 min at 72°C. The product was diluted 1:100 in H 2 O. Table 2 lists the components of the second-stage PCR. The 50-µ L reaction was started with the addition of Stoffel ™Fragment, AmpliTaq ® DNA Polymerase (Perkin-Elmer) in 10 µ L of 1 × Stoffel Buffer to DNA mixture preheated to 85°C. After a denaturation step of 2 min at 97°C, 12 cycles of PCR were carried out with 1 min at 97°C and 6 min at 67°C. A final extension of 20 min at 67°C was used.
First-Stage PCR
Second-Stage PCR
Digestion for Restriction FragmentLength Polymorphisms (RFLP)
The second-stage product (10 µ L) was pipetted into the appropriate restriction buffer with or without 10 U of the diagnostic enzyme in a total volume of 30 µ L and was incubated for 3-16 h under oil.
Electrophoresis on a NonDenaturing TBE Vinyl Gel
Eight microliters of glycerol gelloading Buffer III (11) were added to the digestion. The sample was heated to 65°C for 5 min, and 10 µ L were loaded onto a 0.4-mm-thick 1 ×TBE 6%-8% D-600 ™Vinyl Gel (American Technologies, Malvern, PA, USA) using a sequencing size vertical apparatus. Identical results were obtained using 10%-12% polyacrylamide gel electrophoresis (PAGE)/1 × TBE. Electrophoresis was carried out for 4 h at 500 V, and the gel was dried for 30 min at 80°C.
Phosphor Imaging
The gel was exposed to a PhosphorImager ™plate (Molecular Dynamics, Sunnyvale, CA, USA) for 2-14 h.
Vol. 21, No. 6 (1996) (lanes 3-4) , transfected with mutant matrilysin, and its parent prostate carcinoma cell line DU145 (lanes 1-2) were assayed by the same protocol. Diagnostic Sau 96I fragments that result from an 89th codon CTC →CCC mutation in the integrated cDNA for matrilysin were separated on a 10% 1 ×TBE polyacrylamide gel with the undigestible wildtype matrilysin alleles at 115 bp and digested mutant fragments at the 61/54-bp doublet. The 1:1 DNA mixture is shown in Panel B, lanes 5-6.
Scanning was done on the ImageQuant ™ program (Molecular Dynamics) with a rectangle created slightly larger than the undigested band and one rectangle around the mutant doublet. Background was defined as 0 during volume-integration. Since any radiation incorporated into the undigested band is displayed completely in the doublet when digested, volume-integration of uncut vs. doublet sections of the gel represent directly the ratios of wildtype to mutant alleles carrying the diagnostic restriction site.
RESULTSANDDISCUSSION
Validation of the Assay
The protocol was first used to assay the two cell types for which copy number of wild-type and mutant c -Ha-ras has been established: CD-1 epidermis with two copies of wild-type allele and PDV cells with two copies of wild-type and one copy of mutant allele. Figure 1 is a phosphor-imaged gel of the PCR products from various sources, undigested (odd lanes) and digested with the diagnostic enzyme (even lanes). In Panel A, none of the CD-1 c-Ha-ras PCR product at 176 bp (lane 1) was digested with Xba I (lane 2). This was expected since CD-1 has only wild-type alleles. Part of the PCR product from the PDV DNA could be digested with Xba I (lanes 3 and 4) . Only the digested lane is needed to quantitate the ratio of the two alleles. When radioactive volumes from the phosphor imager for the undigested band at 176 bp were compared to the mutant fraction at doublet 91/85 and then expressed as a ratio of wild-type/total ras alleles, the observed gene dose of 64% closely matched the expected dose (67%) from published data (Table 3) . Therefore, the alleles present in the original genomic DNA sample had been amplified and detected proportionally throughout the various steps of the assay.
To determine absolute gene copies in a cell line, two DNAs combined must demonstrate the correct proportion of alleles. In a CD-1/PDV mixture, PDV would be contributing 2 wild-type alleles and 1 mutant allele per genome, and the CD-1 would contribute 2 wildtype alleles per genome (Table 3) . When equal numbers of genomes from each source are added in a mixture (equal A 260 units), a ratio of 4 wild-type alleles to 1 mutant allele (80% wildtype/total alleles) would be expected. Figure 1A shows the data for the double-source c -Ha-rasDNA PCRs in lanes 7-12, and the quantitation of the observed bands is given in Table 3 . The PCR product from CD-1/PDV (lanes 7 and 8) produces 81% wild-type. These results establish the accuracy of the assay for a mixture of genomic DNAs. Figure 1A (lanes 5 and 6) and Table  3 show the results of CarB tested as a single-source DNA and confirm the CarB to be homozygous for mutant alleles (4) . The mixed sources of DNA can then be used to determine the absolute number of copies of c -Ha-ras . Because CD-1 has two copies of c -Haras and the ratio of 50% wild-type alleles were seen in the CD-1/CarB mixture ( Figure 1A , lane 10 and Table 3),   1058BioTechniques Vol. 21, No. 6 (1996) CarB can be deduced to have two copies of mutated c -Ha-ras . This is confirmed with the other possible mixture, CarB with PDV. The assay was used to establish percent of wild-type to total alleles for the matrilysin gene using a parental DU145 cell line (15) and a DU145 cell line stably transfected with a cDNA for matrilysin that contained a mutant 89th codon. The triploid parental cell line, DU145 PCR-amplified matrilysin gene product at 115 bp could not be digested with Sau 96I ( Figure 1B , lane 2 and Table 3 ), which confirms the absence of the specific point mutation in this gene. However, 25% of the alleles from transfected cell line MR-15 (13) clone 24 can be digested (lane 4). Upon mixing the two cell lines (lanes 5-6), the observed percent wild-type alleles of 85% is as expected for 6 wild-type alleles in a total of 7 gene copies. Therefore, MR-15 clone 24 has 1 mutant copy per 3 wild-type alleles of the matrilysin gene.
Use of Assay for Cell Lines of Unknown Gene Copy Number
ADVANTAGES AND DISADVAN-TAGES
When Southern blots are used for quantitation of copy number, comparisons are made between lanes of various cell lines with known copy number. Although steps have been taken to ensure consistent treatment, each lane has undergone many steps independently. With the assay described here, all the ratios are determined within a single lane. The two alleles are amplified during PCR by the same primer set, with the radioactivity incorporated equally into mutant and wild-type sequences according to the specific activity in that tube. The two types of products (enzyme digestible and resistant) are transferred to a digestion reaction as a proportional mixture and loaded as the same proportional mixture (digested and undigested) onto the gel. Complete digestion of short mutant PCR products is easier to achieve than the digestion of high-molecular-weight genomic DNA on which the accuracy of Southern analyses depends. Enzymes that recognize only four bases can be chosen as a diagnostic enzyme because the digestion of only a short amplified section of the gene greatly reduces the number of fragments seen on the gel. Southern blots that would show both wild-type and mutant alleles from the matrilysin cell line transfected with plasmid cDNA would be difficult to interpret because of the number of theSau 96I sites in the gene and unknown intron sequences.
In cases where a mutation of interest does not produce a diagnostic restriction fragment, rare mutations have been detected by the introduction of a restriction site into a PCR band by the incorporation of a mismatched primer (8, 9, 14, 17) . Using such a primer in the second stage could extend this quantitative assay for use with point mutations that do not produce a natural diagnostic restriction site.
